Report Detail
Global Bictegravir Market Insights, Forecast to 2028
- RnM4387626 |
- 23 February, 2022 |
- Global |
- 105 Pages |
- QYResearch |
- Pharma & Healthcare
Summary:
Market Analysis and Insights: Global Bictegravir Market
Bictegravir is a potent HIV-1 integrase inhibitor primarily used to treat type 1 AIDS without a history of antiretroviral therapy.
(HIV-1) adult patients, it can also be used as an alternative drug for patients with no history of treatment failure and drug resistance and HIV-1 RNA less than 50copies/ml.
Due to the COVID-19 pandemic, the global Bictegravir market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, 97% - 99% accounting for % of the Bictegravir global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Bictegravir market size is valued at US$ million in 2021, while the US and Europe Bictegravir are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Bictegravir landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Bictegravir include Gilead Sciences, Cipla, Laurus Labs, Hetero Drugs Limited, Selleck Chemicals, Shanghai Desano Chemical Pharmaceutical
Shanghai Desano Chemical Pharmaceutical, Changzhou Pharmaceutical Factory, Shanghai Topscience and Jiangsu Coben Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Market Segments
The authors of this research report have explored the key segments: Type and Application. The report offers an in-depth breakdown of type and application segments and their sub-segments. The lucrativeness and growth potential have been looked into by the industry experts in this report. This section of the report also provides sales and revenue forecast data by type and application segments based on sales, price, and revenue for the period 2017-2028. The specialists, to broaden the understanding of the users, have done value chain and raw material analysis in this section.
Segment by Purity
97% - 99%
Above 99%
Segment by Application
Hospitals
Clinics
Labs
Consequence of Covid-19 Pandemic
The authors of this study have enlightened the readers on the rise and effect of the Covid-19 outbreak on the development. They have investigated the changes brought about in the demand/supply side, consumption, supply chain, and sales/manufacturing. The readers will get familiar with the measures that have helped the key players to bring the Bictegravir market back to the pre-covid levels.
Trends & Prospects
In this segment of the report, the specialists have delved into the key growth opportunities that are likely to emerge. This will aid the key players to simplify complex issues related to business and frame future strategies to compete in this competitive environment. This section will certainly assist the players to boldly position their business.
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Competitive Outlook
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and share analysis of the prominent players are also provided in this section. They have also provided reliable sales and revenue data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Gilead Sciences
Cipla
Laurus Labs
Hetero Drugs Limited
Selleck Chemicals
Shanghai Desano Chemical Pharmaceutical
Shanghai Desano Chemical Pharmaceutical
Changzhou Pharmaceutical Factory
Shanghai Topscience
Jiangsu Coben Pharmaceutical
ShenZhen HwaGen Pharmaceutical
Shanghai Haoyuan Chemexpress
Shanghai Systeam Biochem
Frequently Asked Questions
Which is the most lucrative product segment in the Bictegravir market?
Which are the prominent strategies of the Bictegravir market players?
Which factors are increasing the competition in the Bictegravir market?
Which are the recommendations provided by the Bictegravir industry experts?
Which region will witness rewarding growth during the forecast period?
What factors will curb the Bictegravir market growth?
Which product segment will register the fastest growth rate in the Bictegravir market?
Which emerging trends will impact the Bictegravir market growth?
Which are the high-impact rendering factors in the Bictegravir market?
Which companies will maintain their lead on the Bictegravir market?
Table of Contents
1 Study Coverage
- 1.1 Bictegravir Product Introduction
- 1.2 Market by Purity
- 1.2.1 Global Bictegravir Market Size Growth Rate by Purity, 2017 VS 2021 VS 2028
- 1.2.2 97% - 99%
- 1.2.3 Above 99%
- 1.3 Market by Application
- 1.3.1 Global Bictegravir Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
- 1.3.2 Hospitals
- 1.3.3 Clinics
- 1.3.4 Labs
- 1.4 Study Objectives
- 1.5 Years Considered
2 Executive Summary
- 2.1 Global Bictegravir Sales Estimates and Forecasts 2017-2028
- 2.2 Global Bictegravir Revenue Estimates and Forecasts 2017-2028
- 2.3 Global Bictegravir Revenue by Region: 2017 VS 2021 VS 2028
- 2.4 Global Bictegravir Sales by Region
- 2.4.1 Global Bictegravir Sales by Region (2017-2022)
- 2.4.2 Global Sales Bictegravir by Region (2023-2028)
- 2.5 Global Bictegravir Revenue by Region
- 2.5.1 Global Bictegravir Revenue by Region (2017-2022)
- 2.5.2 Global Bictegravir Revenue by Region (2023-2028)
- 2.6 North America
- 2.7 Europe
- 2.8 Asia-Pacific
- 2.9 Latin America
- 2.10 Middle East & Africa
3 Competition by Manufacturers
- 3.1 Global Bictegravir Sales by Manufacturers
- 3.1.1 Global Top Bictegravir Manufacturers by Sales (2017-2022)
- 3.1.2 Global Bictegravir Sales Market Share by Manufacturers (2017-2022)
- 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Bictegravir in 2021
- 3.2 Global Bictegravir Revenue by Manufacturers
- 3.2.1 Global Bictegravir Revenue by Manufacturers (2017-2022)
- 3.2.2 Global Bictegravir Revenue Market Share by Manufacturers (2017-2022)
- 3.2.3 Global Top 10 and Top 5 Companies by Bictegravir Revenue in 2021
- 3.3 Global Bictegravir Sales Price by Manufacturers (2017-2022)
- 3.4 Analysis of Competitive Landscape
- 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Bictegravir Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.4.3 Global Bictegravir Manufacturers Geographical Distribution
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Purity
- 4.1 Global Bictegravir Sales by Purity
- 4.1.1 Global Bictegravir Historical Sales by Purity (2017-2022)
- 4.1.2 Global Bictegravir Forecasted Sales by Purity (2023-2028)
- 4.1.3 Global Bictegravir Sales Market Share by Purity (2017-2028)
- 4.2 Global Bictegravir Revenue by Purity
- 4.2.1 Global Bictegravir Historical Revenue by Purity (2017-2022)
- 4.2.2 Global Bictegravir Forecasted Revenue by Purity (2023-2028)
- 4.2.3 Global Bictegravir Revenue Market Share by Purity (2017-2028)
- 4.3 Global Bictegravir Price by Purity
- 4.3.1 Global Bictegravir Price by Purity (2017-2022)
- 4.3.2 Global Bictegravir Price Forecast by Purity (2023-2028)
5 Market Size by Application
- 5.1 Global Bictegravir Sales by Application
- 5.1.1 Global Bictegravir Historical Sales by Application (2017-2022)
- 5.1.2 Global Bictegravir Forecasted Sales by Application (2023-2028)
- 5.1.3 Global Bictegravir Sales Market Share by Application (2017-2028)
- 5.2 Global Bictegravir Revenue by Application
- 5.2.1 Global Bictegravir Historical Revenue by Application (2017-2022)
- 5.2.2 Global Bictegravir Forecasted Revenue by Application (2023-2028)
- 5.2.3 Global Bictegravir Revenue Market Share by Application (2017-2028)
- 5.3 Global Bictegravir Price by Application
- 5.3.1 Global Bictegravir Price by Application (2017-2022)
- 5.3.2 Global Bictegravir Price Forecast by Application (2023-2028)
6 North America
- 6.1 North America Bictegravir Market Size by Purity
- 6.1.1 North America Bictegravir Sales by Purity (2017-2028)
- 6.1.2 North America Bictegravir Revenue by Purity (2017-2028)
- 6.2 North America Bictegravir Market Size by Application
- 6.2.1 North America Bictegravir Sales by Application (2017-2028)
- 6.2.2 North America Bictegravir Revenue by Application (2017-2028)
- 6.3 North America Bictegravir Market Size by Country
- 6.3.1 North America Bictegravir Sales by Country (2017-2028)
- 6.3.2 North America Bictegravir Revenue by Country (2017-2028)
- 6.3.3 United States
- 6.3.4 Canada
7 Europe
- 7.1 Europe Bictegravir Market Size by Purity
- 7.1.1 Europe Bictegravir Sales by Purity (2017-2028)
- 7.1.2 Europe Bictegravir Revenue by Purity (2017-2028)
- 7.2 Europe Bictegravir Market Size by Application
- 7.2.1 Europe Bictegravir Sales by Application (2017-2028)
- 7.2.2 Europe Bictegravir Revenue by Application (2017-2028)
- 7.3 Europe Bictegravir Market Size by Country
- 7.3.1 Europe Bictegravir Sales by Country (2017-2028)
- 7.3.2 Europe Bictegravir Revenue by Country (2017-2028)
- 7.3.3 Germany
- 7.3.4 France
- 7.3.5 U.K.
- 7.3.6 Italy
- 7.3.7 Russia
8 Asia Pacific
- 8.1 Asia Pacific Bictegravir Market Size by Purity
- 8.1.1 Asia Pacific Bictegravir Sales by Purity (2017-2028)
- 8.1.2 Asia Pacific Bictegravir Revenue by Purity (2017-2028)
- 8.2 Asia Pacific Bictegravir Market Size by Application
- 8.2.1 Asia Pacific Bictegravir Sales by Application (2017-2028)
- 8.2.2 Asia Pacific Bictegravir Revenue by Application (2017-2028)
- 8.3 Asia Pacific Bictegravir Market Size by Region
- 8.3.1 Asia Pacific Bictegravir Sales by Region (2017-2028)
- 8.3.2 Asia Pacific Bictegravir Revenue by Region (2017-2028)
- 8.3.3 China
- 8.3.4 Japan
- 8.3.5 South Korea
- 8.3.6 India
- 8.3.7 Australia
- 8.3.8 China Taiwan
- 8.3.9 Indonesia
- 8.3.10 Thailand
- 8.3.11 Malaysia
9 Latin America
- 9.1 Latin America Bictegravir Market Size by Purity
- 9.1.1 Latin America Bictegravir Sales by Purity (2017-2028)
- 9.1.2 Latin America Bictegravir Revenue by Purity (2017-2028)
- 9.2 Latin America Bictegravir Market Size by Application
- 9.2.1 Latin America Bictegravir Sales by Application (2017-2028)
- 9.2.2 Latin America Bictegravir Revenue by Application (2017-2028)
- 9.3 Latin America Bictegravir Market Size by Country
- 9.3.1 Latin America Bictegravir Sales by Country (2017-2028)
- 9.3.2 Latin America Bictegravir Revenue by Country (2017-2028)
- 9.3.3 Mexico
- 9.3.4 Brazil
- 9.3.5 Argentina
- 9.3.6 Colombia
10 Middle East and Africa
- 10.1 Middle East and Africa Bictegravir Market Size by Purity
- 10.1.1 Middle East and Africa Bictegravir Sales by Purity (2017-2028)
- 10.1.2 Middle East and Africa Bictegravir Revenue by Purity (2017-2028)
- 10.2 Middle East and Africa Bictegravir Market Size by Application
- 10.2.1 Middle East and Africa Bictegravir Sales by Application (2017-2028)
- 10.2.2 Middle East and Africa Bictegravir Revenue by Application (2017-2028)
- 10.3 Middle East and Africa Bictegravir Market Size by Country
- 10.3.1 Middle East and Africa Bictegravir Sales by Country (2017-2028)
- 10.3.2 Middle East and Africa Bictegravir Revenue by Country (2017-2028)
- 10.3.3 Turkey
- 10.3.4 Saudi Arabia
11 Company Profiles
- 11.1 Gilead Sciences
- 11.1.1 Gilead Sciences Corporation Information
- 11.1.2 Gilead Sciences Overview
- 11.1.3 Gilead Sciences Bictegravir Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.1.4 Gilead Sciences Bictegravir Product Model Numbers, Pictures, Descriptions and Specifications
- 11.1.5 Gilead Sciences Recent Developments
- 11.2 Cipla
- 11.2.1 Cipla Corporation Information
- 11.2.2 Cipla Overview
- 11.2.3 Cipla Bictegravir Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.2.4 Cipla Bictegravir Product Model Numbers, Pictures, Descriptions and Specifications
- 11.2.5 Cipla Recent Developments
- 11.3 Laurus Labs
- 11.3.1 Laurus Labs Corporation Information
- 11.3.2 Laurus Labs Overview
- 11.3.3 Laurus Labs Bictegravir Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.3.4 Laurus Labs Bictegravir Product Model Numbers, Pictures, Descriptions and Specifications
- 11.3.5 Laurus Labs Recent Developments
- 11.4 Hetero Drugs Limited
- 11.4.1 Hetero Drugs Limited Corporation Information
- 11.4.2 Hetero Drugs Limited Overview
- 11.4.3 Hetero Drugs Limited Bictegravir Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.4.4 Hetero Drugs Limited Bictegravir Product Model Numbers, Pictures, Descriptions and Specifications
- 11.4.5 Hetero Drugs Limited Recent Developments
- 11.5 Selleck Chemicals
- 11.5.1 Selleck Chemicals Corporation Information
- 11.5.2 Selleck Chemicals Overview
- 11.5.3 Selleck Chemicals Bictegravir Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.5.4 Selleck Chemicals Bictegravir Product Model Numbers, Pictures, Descriptions and Specifications
- 11.5.5 Selleck Chemicals Recent Developments
- 11.6 Shanghai Desano Chemical Pharmaceutical
Shanghai Desano Chemical Pharmaceutical
- 11.6.1 Shanghai Desano Chemical Pharmaceutical
Shanghai Desano Chemical Pharmaceutical Corporation Information
- 11.6.2 Shanghai Desano Chemical Pharmaceutical
Shanghai Desano Chemical Pharmaceutical Overview
- 11.6.3 Shanghai Desano Chemical Pharmaceutical
Shanghai Desano Chemical Pharmaceutical Bictegravir Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.6.4 Shanghai Desano Chemical Pharmaceutical
Shanghai Desano Chemical Pharmaceutical Bictegravir Product Model Numbers, Pictures, Descriptions and Specifications
- 11.6.5 Shanghai Desano Chemical Pharmaceutical
Shanghai Desano Chemical Pharmaceutical Recent Developments
- 11.7 Changzhou Pharmaceutical Factory
- 11.7.1 Changzhou Pharmaceutical Factory Corporation Information
- 11.7.2 Changzhou Pharmaceutical Factory Overview
- 11.7.3 Changzhou Pharmaceutical Factory Bictegravir Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.7.4 Changzhou Pharmaceutical Factory Bictegravir Product Model Numbers, Pictures, Descriptions and Specifications
- 11.7.5 Changzhou Pharmaceutical Factory Recent Developments
- 11.8 Shanghai Topscience
- 11.8.1 Shanghai Topscience Corporation Information
- 11.8.2 Shanghai Topscience Overview
- 11.8.3 Shanghai Topscience Bictegravir Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.8.4 Shanghai Topscience Bictegravir Product Model Numbers, Pictures, Descriptions and Specifications
- 11.8.5 Shanghai Topscience Recent Developments
- 11.9 Jiangsu Coben Pharmaceutical
- 11.9.1 Jiangsu Coben Pharmaceutical Corporation Information
- 11.9.2 Jiangsu Coben Pharmaceutical Overview
- 11.9.3 Jiangsu Coben Pharmaceutical Bictegravir Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.9.4 Jiangsu Coben Pharmaceutical Bictegravir Product Model Numbers, Pictures, Descriptions and Specifications
- 11.9.5 Jiangsu Coben Pharmaceutical Recent Developments
- 11.10 ShenZhen HwaGen Pharmaceutical
- 11.10.1 ShenZhen HwaGen Pharmaceutical Corporation Information
- 11.10.2 ShenZhen HwaGen Pharmaceutical Overview
- 11.10.3 ShenZhen HwaGen Pharmaceutical Bictegravir Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.10.4 ShenZhen HwaGen Pharmaceutical Bictegravir Product Model Numbers, Pictures, Descriptions and Specifications
- 11.10.5 ShenZhen HwaGen Pharmaceutical Recent Developments
- 11.11 Shanghai Haoyuan Chemexpress
- 11.11.1 Shanghai Haoyuan Chemexpress Corporation Information
- 11.11.2 Shanghai Haoyuan Chemexpress Overview
- 11.11.3 Shanghai Haoyuan Chemexpress Bictegravir Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.11.4 Shanghai Haoyuan Chemexpress Bictegravir Product Model Numbers, Pictures, Descriptions and Specifications
- 11.11.5 Shanghai Haoyuan Chemexpress Recent Developments
- 11.12 Shanghai Systeam Biochem
- 11.12.1 Shanghai Systeam Biochem Corporation Information
- 11.12.2 Shanghai Systeam Biochem Overview
- 11.12.3 Shanghai Systeam Biochem Bictegravir Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.12.4 Shanghai Systeam Biochem Bictegravir Product Model Numbers, Pictures, Descriptions and Specifications
- 11.12.5 Shanghai Systeam Biochem Recent Developments
12 Industry Chain and Sales Channels Analysis
- 12.1 Bictegravir Industry Chain Analysis
- 12.2 Bictegravir Key Raw Materials
- 12.2.1 Key Raw Materials
- 12.2.2 Raw Materials Key Suppliers
- 12.3 Bictegravir Production Mode & Process
- 12.4 Bictegravir Sales and Marketing
- 12.4.1 Bictegravir Sales Channels
- 12.4.2 Bictegravir Distributors
- 12.5 Bictegravir Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
- 13.1 Bictegravir Industry Trends
- 13.2 Bictegravir Market Drivers
- 13.3 Bictegravir Market Challenges
- 13.4 Bictegravir Market Restraints
14 Key Findings in The Global Bictegravir Study
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.2 Data Source
- 15.2 Author Details
Summary:
Get latest Market Research Reports on Bictegravir. Industry analysis & Market Report on Bictegravir is a syndicated market report, published as Global Bictegravir Market Insights, Forecast to 2028. It is complete Research Study and Industry Analysis of Bictegravir market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
